Kline Kyle
SEC CIK 2080625 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GMED | GLOBUS MEDICAL INC | SVP, CFO | 3,594 | — | $2.03M | 4 | 2025-12-01 | 2026-01-08 |
Most active insiders at GMED, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ZARRILLI STEPHEN T | Dir | — | $4.28M |
| 2 | Davidar David D | Dir | — | $4.17M |
| 3 | Huller Kelly | SVP, GC, Corp. Sec | — | $3.44M |
| 4 | TOBIN JAMES R | Dir | — | $2.24M |
| 5 | Kline Kyle | SVP, CFO | — | $2.03M |
| 6 | RHOADS ANN D | Dir | — | $818.0K |
| 7 | Norwalk Leslie V | Dir | — | $557.6K |
| 8 | Paul David C | Executive COB, Dir, 10% | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-12 | 2026-01-08 | GMED | GLOBUS MEDICAL INC | Kline Kyle | SVP, CFO | M - OptEx | $51.87 | +3,594 | 3,594 | New | +$186.4K |
| DT | 2026-01-12 | 2026-01-08 | GMED | GLOBUS MEDICAL INC | Kline Kyle | SVP, CFO | S - Sale+OE | $101.10 | -3,594 | 0 | -100% | -$363.4K |
| DMT | 2025-12-03 | 2025-12-01 | GMED | GLOBUS MEDICAL INC | Kline Kyle | SVP, CFO | M - OptEx | $59.86 | +18.5K | 18.5K | New | +$1.11M |
| DT | 2025-12-03 | 2025-12-01 | GMED | GLOBUS MEDICAL INC | Kline Kyle | SVP, CFO | S - Sale+OE | $90.00 | -18.5K | 0 | -100% | -$1.67M |
Purchase Sale Sale after option exercise All abbreviations